AbCellera Biologics Inc (ABCL)
3.305
+0.18
(+5.59%)
USD |
NASDAQ |
Jan 06, 16:00
3.305
0.00 (0.00%)
After-Hours: 19:25
AbCellera Biologics Total Assets (Quarterly): 1.393B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 3.814M |
| Lexaria Bioscience Corp | 8.868M |
| Xenon Pharmaceuticals Inc | 835.90M |
| ESSA Pharma Inc | 128.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 314.73M |
| Shareholders Equity (Quarterly) | 1.078B |
| Current Ratio | 9.336 |